STAT3 and endometrial cancer: We have previously demonstrated that IL11 promotes endometrial cancer cell migration in vitro, via STAT3 [19] and that blockade of IL11 receptor (R) α reduces grade-1 and grade-2 derived human endometrial epithelial cell line xenograft tumour growth and metastasis in mouse models [20].